Title
Category
Credits
Event date
Cost
- Covid-19
- Disease management
- Infectious diseases
- 1.00 ACPE - Pharmacists
- 1.00 ACPE - Pharmacy Technicians
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 APA - Psychologists
- 1.00 Attendance - General Attendance
- 1.00 ASWB - Social Workers
$0.00
This activity focuses on the challenges faced by health care professionals (HCPs) in New York during the height of the COVID-19 pandemic. It details ethical dilemmas caused by workforce and resource allocation issues, as well as palliative care practices used to support patients and their loved ones.
- Covid-19
- Disease management
- Infectious diseases
- 1.00 ACPE - Pharmacists
- 1.00 ACPE - Pharmacy Technicians
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 APA - Psychologists
- 1.00 Attendance - General Attendance
- 1.00 ASWB - Social Workers
$0.00
This activity focuses on the current state of COVID-19 vaccine development. It discusses which vaccine types are being developed and where they are in the clinical trial process. Additionally, this activity identifies what it means for a health system to participate in a vaccine study and how health care professionals can make informed decisions about vaccines with limited available data.
- Covid-19
- Disease management
- Infectious diseases
- 1.00 ACPE - Pharmacists
- 1.00 ACPE - Pharmacy Technicians
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 APA - Psychologists
- 1.00 Attendance - General Attendance
- 1.00 ASWB - Social Workers
$0.00
This activity focuses on monoclonal antibodies and how they are used in therapeutics, including clinical trials for COVID-19. It discusses the risks associated with using monoclonal antibodies in infectious disease treatment and provides detailed information regarding antibody therapies currently under investigation.
- Disease management
- Pediatrics
- Wellness
- 1.00 ACPE - Pharmacists
- 1.00 ACPE - Pharmacy Technicians
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 APA - Psychologists
- 1.00 Attendance - General Attendance
- 1.00 CCMC - General - Case Managers
- 1.00 ASWB - Social Workers
$0.00
This activity will discuss the importance of data and evidence regarding the use of genetics/genomics in treatment planning.
- Behavioral health
- Health equity
- 0.75 AMA - Physicians
- 0.75 ANCC - Nurses
- 0.75 APA - Psychologists
- 0.75 Attendance - General Attendance
- 0.75 ASWB - Social Workers
$0.00
This activity focuses on educating health care professionals about the impact of racism and bias on their patients’ SDOH, C-ACE, and short- and long-term mental and physical health outcomes. In addition, risk factors for C-ACE, as well as the important role of managed care in decreasing C-ACE among minority patients, will be discussed.
- Behavioral health
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 APA - Psychologists
- 1.00 Attendance - General Attendance
- 1.00 ASWB - Social Workers
$0.00
This activity will provide an overview of the psychiatric conditions experienced by women across their lifespans and alert HCPs to differences in symptom patterns, evaluation, and treatment, as compared to those of men. In addition, diagnostic criteria and management considerations for psychiatric conditions specific to women’s reproductive lifespans, such as those associated with perimenopause, postmenopause, pregnancy, the postpartum period, and the menstrual cycle, will be discussed.
- Covid-19
- Disease management
- Infectious diseases
- 1.00 ACPE - Pharmacists
- 1.00 ACPE - Pharmacy Technicians
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 APA - Psychologists
- 1.00 Attendance - General Attendance
- 1.00 ASWB - Social Workers
$0.00
This activity will identify pathways to creating effective, practical and sustainable testing strategies for COVID-19 that can accelerate a return to normalcy and allow schools and other facilities to remain open. It will relay to participants how determining the goal of testing is the key factor to establishing an optimal testing strategy through consideration of multiple factors, including test type, sensitivity and turnaround time as well as program implementation and costs. Current testing programs will be discussed, examining how the selection of these elements can be adapted to satisfy the needs of the target community as well as the testing program’s goals. The roles that communication and partnership can play in establishing effective strategies, enhancing safety, enabling improved implementation and shaping public policy will also be examined.
- Behavioral health
- Covid-19
- Infectious diseases
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 APA - Psychologists
- 1.00 Attendance - General Attendance
- 1.00 ASWB - Social Workers
$0.00
This activity will provide education surrounding current trends in mental health issues and increases in SUD, OUD, and SI that have been associated with the COVID-19 pandemic. It will discuss possible etiologies for these changes and will highlight areas of focus for health care providers (HCPs) that can induce potential changes in approaches to patient care that can effectively promote improved evaluation, treatment, recovery, and health moving forward.
- Behavioral health
- 2.50 ACPE - Pharmacists
- 2.50 ACPE - Pharmacy Technicians
- 2.50 AMA - Physicians
- 2.50 ANCC - Nurses
- 2.50 APA - Psychologists
- 2.50 Attendance - General Attendance
- 2.50 CCMC - General - Case Managers
- 2.50 ASWB - Social Workers
$0.00
This activity will equip participants with practical tools that will help strengthen their skills in facilitating conversations and activities and conducting follow-up interventions with individuals experiencing complex health and social needs. As a result of this increased knowledge, learners can feel more confident in their ability to foster authentic healing relationships that build resiliency and avoid re-traumatization.
- Disease management
- 1.00 ACPE - Pharmacists
- 1.00 ACPE - Pharmacy Technicians
- 1.00 AMA - Physicians
- 1.00 ANCC - Nurses
- 1.00 APA - Psychologists
- 1.00 Attendance - General Attendance
- 1.00 ASWB - Social Workers
$0.00
This activity will present HCPs with the information necessary to evaluate kidney health in individuals with type 2 diabetes mellitus (T2DM) and will discuss CKD risk stratification, including interpretation of albuminuria levels and estimated glomerular filtration rate (eGFR). Interventions that can reduce progression of disease, likelihood of hospitalization and costs will be identified, and recent data about effective treatment regimens and their indications for improving outcomes will be examined. Additionally, early strategies to decrease the risk for CVD and ESRD in these individuals will be defined, with a review of the pathophysiology of progression of these disorders.